Semaglutide Therapy for Alcohol Reduction (STAR) | MicrobiomeTrials← Back to trialsNCT06015893
Semaglutide Therapy for Alcohol Reduction (STAR)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-10-17Est. Completion: 2027-03-31
Enrollment target: 63 participants Locations- National Institute on Drug Abuse, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Chronic Pain
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain…
San Francisco, United StatesEst. completion Jan 31, 2028
Autism Spectrum Disorder (ASD)
The goal of this sequential multiple assignment randomized trial is to conduct a preliminary evaluation of Our Love, Our…
Seoul, South KoreaEst. completion Mar 31, 2028